×
About 6,107 results

ALLMedicine™ Hidradenitis Suppurativa Center

Research & Reviews  2,757 results

Efficacy of non-surgical monotherapies for hidradenitis suppurativa: a systematic revie...
https://doi.org/10.1080/09546634.2021.1927949
The Journal of Dermatological Treatment; Gupta AK, Shear NH et. al.

May 7th, 2021 - We determined the relative efficacy of non-surgical monotherapies for hidradenitis suppurativa (HS). Network meta-analyses were conducted to determine treatments' surface under the cumulative ranking curve (SUCRA) value (i.e., an estimate that ran...

Assessing Psychological Interventions for Hidradenitis Suppurativa as a First Step Towa...
https://doi.org/10.12788/cutis.0195
Cutis Misitzis A, Katoulis A

May 6th, 2021 - Assessing Psychological Interventions for Hidradenitis Suppurativa as a First Step Toward Patient-Centered Practice.|2021|Misitzis A,Katoulis A,|

A safety review of biologic therapies for the management of hidradenitis suppurativa an...
https://doi.org/10.1080/14740338.2021.1924147
Expert Opinion on Drug Safety; Holcomb ZE, Porter ML et. al.

Apr 29th, 2021 - Hidradenitis suppurativa (HS) is a chronic, debilitating inflammatory skin disorder characterized by nodules, abscesses, fistulae, and significant scarring in intertriginous areas rich in apocrine glands. Immunomodulator drugs, including biologics...

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex; Is It a New Varian...
https://doi.org/10.1177/12034754211010145
Journal of Cutaneous Medicine and Surgery; Fletcher J, Posso-De Los Rios C et. al.

Apr 28th, 2021 - Hidradenitis suppurativa and steatocystoma multiplex may coexist in the same patient. The overlap of these 2 conditions could be suggestive of an unrecognized defect in follicular proliferation mutual in the pathogenesis of both conditions. Here w...

Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: ...
https://doi.org/10.1097/MEG.0000000000002170
European Journal of Gastroenterology & Hepatology; Salvatori S, Marafini I et. al.

Apr 27th, 2021 - The introduction of TNF blockers in the therapeutic armamentarium of inflammatory bowel diseases (IBD) has largely advanced the way by which clinicians manage these disorders. However, some patients develop de novo immune-mediated diseases during ...

see more →

Guidelines  1 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 4th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

see more →

Clinicaltrials.gov  2,985 results

Efficacy of non-surgical monotherapies for hidradenitis suppurativa: a systematic revie...
https://doi.org/10.1080/09546634.2021.1927949
The Journal of Dermatological Treatment; Gupta AK, Shear NH et. al.

May 7th, 2021 - We determined the relative efficacy of non-surgical monotherapies for hidradenitis suppurativa (HS). Network meta-analyses were conducted to determine treatments' surface under the cumulative ranking curve (SUCRA) value (i.e., an estimate that ran...

Assessing Psychological Interventions for Hidradenitis Suppurativa as a First Step Towa...
https://doi.org/10.12788/cutis.0195
Cutis Misitzis A, Katoulis A

May 6th, 2021 - Assessing Psychological Interventions for Hidradenitis Suppurativa as a First Step Toward Patient-Centered Practice.|2021|Misitzis A,Katoulis A,|

A safety review of biologic therapies for the management of hidradenitis suppurativa an...
https://doi.org/10.1080/14740338.2021.1924147
Expert Opinion on Drug Safety; Holcomb ZE, Porter ML et. al.

Apr 29th, 2021 - Hidradenitis suppurativa (HS) is a chronic, debilitating inflammatory skin disorder characterized by nodules, abscesses, fistulae, and significant scarring in intertriginous areas rich in apocrine glands. Immunomodulator drugs, including biologics...

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex; Is It a New Varian...
https://doi.org/10.1177/12034754211010145
Journal of Cutaneous Medicine and Surgery; Fletcher J, Posso-De Los Rios C et. al.

Apr 28th, 2021 - Hidradenitis suppurativa and steatocystoma multiplex may coexist in the same patient. The overlap of these 2 conditions could be suggestive of an unrecognized defect in follicular proliferation mutual in the pathogenesis of both conditions. Here w...

Two Studies Add to Knowledge Base of Biosimilar Use in Psoriasis, HS
https://www.medscape.com/viewarticle/950197

Apr 28th, 2021 - A cohort study of psoriasis patients in Denmark found that a nonmedical switch from brand name adalimumab to adalimumab biosimilars was not associated with drug retention at 1 year. And another study, a small, single-center retrospective study of ...

see more →

News  271 results

Two Studies Add to Knowledge Base of Biosimilar Use in Psoriasis, HS
https://www.medscape.com/viewarticle/950197

Apr 28th, 2021 - A cohort study of psoriasis patients in Denmark found that a nonmedical switch from brand name adalimumab to adalimumab biosimilars was not associated with drug retention at 1 year. And another study, a small, single-center retrospective study of ...

New Analysis Eyes the Surgical Landscape for Hidradenitis Suppurativa
https://www.medscape.com/viewarticle/948026

Mar 23rd, 2021 - Among patients who undergo surgery for hidradenitis suppurativa (HS), wide excision and flap-based reconstruction are associated with lower postsurgical recurrence, yet these options should be balanced against potentially higher morbidity of exten...

Inflammatory Skin Diseases and CKD Risk: What’s the Link?
https://www.medscape.com/viewarticle/947916

Mar 22nd, 2021 - Takeaway Atopic eczema, psoriasis and hidradenitis suppurativa were weakly associated with chronic kidney disease (CKD), independent of obesity, cardiovascular morbidity or non-biologic nephrotoxic skin medications. No evidence supporting this ass...

Adalimumab Enhances Primary Wound Closure After HS Surgery
https://www.medscape.com/viewarticle/945207

Feb 2nd, 2021 - Delaying surgical reconstruction of fistula structures until after patients with hidradenitis suppurativa (HS) have been on adalimumab for a minimum of 6 months transforms primary wound closure into a highly attractive option, a pilot study sugges...

Oral JAK1 Inhibitor Shows Promise for Hidradenitis Suppurativa
https://www.medscape.com/viewarticle/944781

Jan 26th, 2021 - A once-daily oral selective Janus kinase 1 inhibitor demonstrated promising safety and efficacy for the treatment of moderate to severe hidradenitis suppurativa (HS) in a pair of small, randomized, phase 2 studies that established proof-of-concept...

see more →

Patient Education  93 results see all →